Dr. Jyoti Patel, MD
Claim this profileNorthwestern University
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
20 drugs studied
Area of expertise
1Lung Cancer
Stage IV
EGFR positive
Stage III
2Non-Small Cell Lung Cancer
Stage IV
EGFR positive
Stage III
Affiliated Hospitals
Clinical Trials Jyoti Patel, MD is currently running
TAK-500 + Pembrolizumab
for Advanced Solid Cancers
This trial is testing a new drug called TAK-500, alone or with pembrolizumab, in adults with advanced or spreading solid tumors. The goal is to see if TAK-500 is safe and effective in shrinking these tumors.
Recruiting1 award Phase 1 & 213 criteria
BLU-451
for Lung Cancer
This trial is testing a new drug called BLU-451, alone and with chemotherapy, in patients with advanced cancers that have specific EGFR mutations. The drug works by blocking signals that make cancer cells grow.
Recruiting1 award Phase 1 & 214 criteria
More about Jyoti Patel, MD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Jyoti Patel, MD has experience with
- Carboplatin
- Pemetrexed
- Nivolumab
- Pembrolizumab
- Cisplatin
- Avutometinib (VS-6766)
Breakdown of trials Jyoti Patel, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Epidermal Growth Factor Receptor Mutations
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jyoti Patel, MD specialize in?
Jyoti Patel, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are EGFR positive.
Is Jyoti Patel, MD currently recruiting for clinical trials?
Yes, Jyoti Patel, MD is currently recruiting for 3 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Jyoti Patel, MD has studied deeply?
Yes, Jyoti Patel, MD has studied treatments such as Carboplatin, Pemetrexed, Nivolumab.
What is the best way to schedule an appointment with Jyoti Patel, MD?
Apply for one of the trials that Jyoti Patel, MD is conducting.
What is the office address of Jyoti Patel, MD?
The office of Jyoti Patel, MD is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.